Gregory Renza
Stock Analyst at Truist Securities
(3.18)
# 512
Out of 5,182 analysts
257
Total ratings
38.14%
Success rate
3.85%
Average return
Main Sectors:
Stocks Rated by Gregory Renza
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Maintains: Hold | $325 → $327 | $328.03 | -0.31% | 20 | May 1, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $801 → $796 | $716.03 | +11.17% | 5 | Apr 30, 2026 | |
| AGIO Agios Pharmaceuticals | Maintains: Buy | $39 → $36 | $27.50 | +30.91% | 9 | Apr 30, 2026 | |
| VRDN Viridian Therapeutics | Maintains: Buy | $36 → $33 | $17.29 | +90.86% | 14 | Apr 21, 2026 | |
| ONC BeOne Medicines AG | Maintains: Buy | $400 → $412 | $311.68 | +32.19% | 4 | Feb 27, 2026 | |
| GILD Gilead Sciences | Maintains: Buy | $145 → $152 | $135.35 | +12.30% | 3 | Feb 11, 2026 | |
| CGON CG Oncology | Maintains: Buy | $66 → $75 | $68.92 | +8.82% | 6 | Feb 10, 2026 | |
| IDYA IDEAYA Biosciences | Maintains: Buy | $59 → $60 | $28.43 | +111.04% | 14 | Jan 6, 2026 | |
| FULC Fulcrum Therapeutics | Maintains: Buy | $14 → $18 | $7.06 | +154.96% | 5 | Dec 11, 2025 | |
| CATX Perspective Therapeutics | Assumes: Buy | $8 → $12 | $3.64 | +229.67% | 7 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $23 → $30 | $16.56 | +81.16% | 12 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $29 | $12.90 | +124.81% | 10 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $4.98 | +120.88% | 7 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $140 | $102.70 | +36.32% | 1 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $3.64 | +147.59% | 2 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $10 | $4.92 | +103.25% | 4 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $51 | $22.01 | +131.71% | 1 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $140 | $127.45 | +9.85% | 1 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $45 → $50 | $46.42 | +7.71% | 11 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $26 | $22.18 | +17.22% | 16 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $8 | $3.78 | +111.92% | 12 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $5 | $1.38 | +262.32% | 11 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $182 → $172 | $225.00 | -23.56% | 14 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $113 → $38 | $57.19 | -34.43% | 14 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $12 | $7.92 | +51.52% | 6 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $16 → $14 | $5.84 | +139.73% | 10 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $18 | $23.93 | -24.78% | 11 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $68 → $48 | $0.94 | +4,987.49% | 4 | Jan 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $110 → $20 | $8.10 | +147.07% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $16 | $0.96 | +1,561.99% | 7 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $2,160 → $180 | $22.45 | +701.78% | 4 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $100 → $80 | $0.87 | +9,076.42% | 5 | Mar 16, 2022 |
Amgen
May 1, 2026
Maintains: Hold
Price Target: $325 → $327
Current: $328.03
Upside: -0.31%
Regeneron Pharmaceuticals
Apr 30, 2026
Maintains: Buy
Price Target: $801 → $796
Current: $716.03
Upside: +11.17%
Agios Pharmaceuticals
Apr 30, 2026
Maintains: Buy
Price Target: $39 → $36
Current: $27.50
Upside: +30.91%
Viridian Therapeutics
Apr 21, 2026
Maintains: Buy
Price Target: $36 → $33
Current: $17.29
Upside: +90.86%
BeOne Medicines AG
Feb 27, 2026
Maintains: Buy
Price Target: $400 → $412
Current: $311.68
Upside: +32.19%
Gilead Sciences
Feb 11, 2026
Maintains: Buy
Price Target: $145 → $152
Current: $135.35
Upside: +12.30%
CG Oncology
Feb 10, 2026
Maintains: Buy
Price Target: $66 → $75
Current: $68.92
Upside: +8.82%
IDEAYA Biosciences
Jan 6, 2026
Maintains: Buy
Price Target: $59 → $60
Current: $28.43
Upside: +111.04%
Fulcrum Therapeutics
Dec 11, 2025
Maintains: Buy
Price Target: $14 → $18
Current: $7.06
Upside: +154.96%
Perspective Therapeutics
Nov 24, 2025
Assumes: Buy
Price Target: $8 → $12
Current: $3.64
Upside: +229.67%
Nov 24, 2025
Assumes: Buy
Price Target: $23 → $30
Current: $16.56
Upside: +81.16%
Nov 24, 2025
Initiates: Buy
Price Target: $29
Current: $12.90
Upside: +124.81%
Nov 24, 2025
Initiates: Buy
Price Target: $11
Current: $4.98
Upside: +120.88%
Nov 24, 2025
Initiates: Buy
Price Target: $140
Current: $102.70
Upside: +36.32%
Nov 24, 2025
Initiates: Buy
Price Target: $9
Current: $3.64
Upside: +147.59%
Nov 24, 2025
Initiates: Hold
Price Target: $10
Current: $4.92
Upside: +103.25%
Nov 24, 2025
Initiates: Buy
Price Target: $51
Current: $22.01
Upside: +131.71%
Nov 24, 2025
Initiates: Buy
Price Target: $140
Current: $127.45
Upside: +9.85%
Jul 8, 2025
Downgrades: Sector Perform
Price Target: $45 → $50
Current: $46.42
Upside: +7.71%
May 19, 2025
Reiterates: Outperform
Price Target: $26
Current: $22.18
Upside: +17.22%
May 15, 2025
Reiterates: Outperform
Price Target: $8
Current: $3.78
Upside: +111.92%
May 14, 2025
Reiterates: Sector Perform
Price Target: $5
Current: $1.38
Upside: +262.32%
May 7, 2025
Maintains: Outperform
Price Target: $182 → $172
Current: $225.00
Upside: -23.56%
Apr 16, 2025
Maintains: Sector Perform
Price Target: $113 → $38
Current: $57.19
Upside: -34.43%
Mar 26, 2025
Reiterates: Outperform
Price Target: $12
Current: $7.92
Upside: +51.52%
Mar 21, 2025
Maintains: Outperform
Price Target: $16 → $14
Current: $5.84
Upside: +139.73%
Jan 14, 2025
Reiterates: Sector Perform
Price Target: $18
Current: $23.93
Upside: -24.78%
Jan 9, 2025
Maintains: Outperform
Price Target: $68 → $48
Current: $0.94
Upside: +4,987.49%
Nov 5, 2024
Downgrades: Sector Perform
Price Target: $110 → $20
Current: $8.10
Upside: +147.07%
Aug 14, 2024
Reiterates: Outperform
Price Target: $16
Current: $0.96
Upside: +1,561.99%
Jun 27, 2023
Downgrades: Sector Perform
Price Target: $2,160 → $180
Current: $22.45
Upside: +701.78%
Mar 16, 2022
Maintains: Sector Perform
Price Target: $100 → $80
Current: $0.87
Upside: +9,076.42%